Dupilumab Provides Meaningful Clinical Responses in Harlequin Ichthyosis ( ABCA12 ‐ nEDD ): A Report of Two Cases
Pediatric Dermatology · 2026-07-27
DOI: 10.1111/pde.70327 ↗At a glance
Fallbericht in Pediatric Dermatology, published online on 2026-07-27. Written by Minu Jose Chiramel and 3 co-authors. Institution: Department of Pediatric Dermatology, The Hospital for Sick Children, Toronto, Canada. 11 references.
Abstract (original language)
Harlequin ichthyosis (HI) is a rare epidermal differentiation disorder characterized by thick hyperkeratotic plates, fissuring, and high neonatal morbidity. Long‐term management remains challenging. We report two children with genetically confirmed HI who demonstrated meaningful improvement in pruritus, erythema, scaling, and overall well‐being following dupilumab therapy, suggesting a potential role for IL‐4/IL‐13 blockade as an adjunct or alternative treatment in HI.
Subjects
Author keywords
Authors and institutions
- Department of Pediatric Dermatology, The Hospital for Sick Children, Toronto, Canada.
- Washington University School of Medicine, St Louis, Missouri, USA.
- Division of Pediatric Dermatology, SSM Health/Cardinal, Glennon Children's Hospital, Departments of Pediatrics and Dermatology, St Louis University School of Medicine, Missouri, USA.
ORCID profiles: Minu Jose Chiramel, Cynthia Chen, Rebecca Levy
Cite
APA
Chiramel, M. J., Chen, C., Siegfried, E., & Levy, R. (2026). Dupilumab Provides Meaningful Clinical Responses in Harlequin Ichthyosis ( ABCA12 ‐ nEDD ): A Report of Two Cases. Pediatric Dermatology. https://doi.org/10.1111/pde.70327
Vancouver
Chiramel MJ, Chen C, Siegfried E, Levy R. Dupilumab Provides Meaningful Clinical Responses in Harlequin Ichthyosis ( ABCA12 ‐ nEDD ): A Report of Two Cases. Pediatric Dermatology. 2026. doi:10.1111/pde.70327
BibTeX
@article{Chiramel2026,
author = {Chiramel, Minu Jose and Chen, Cynthia and Siegfried, Elaine and Levy, Rebecca},
title = {Dupilumab Provides Meaningful Clinical Responses in Harlequin Ichthyosis ( ABCA12 ‐ nEDD ): A Report of Two Cases},
journal = {Pediatric Dermatology},
year = {2026},
doi = {10.1111/pde.70327}
}
EUVIMED